Personalized Follow-up for Cervical Cancer Screening
Personalized Risk-based Follow-up of Cervical Cancer Screening in Practice (PREDICT)
This project helps doctors use new guidelines to give you the best personalized follow-up care after cervical cancer screening.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11099679 on NIH RePORTER |
What this research studies
Cervical cancer can often be prevented with early detection and proper care, but sometimes people are diagnosed because they don't get screened enough or miss follow-up appointments. New guidelines for cervical cancer screening and managing abnormal results are very personalized, aiming to prevent cancer while avoiding unnecessary tests. However, these guidelines can be complicated for doctors to put into practice, especially with current electronic health records. This work aims to make it easier for healthcare providers to offer personalized, risk-based follow-up, ensuring you receive the right care at the right time.
Who could benefit from this research
Good fit: Patients who undergo cervical cancer screening and require follow-up care based on their results would be the focus of this improved system.
Not a fit: Patients who do not undergo cervical cancer screening or who have no abnormal results requiring follow-up would not directly benefit from this specific improvement in follow-up protocols.
Why it matters
Potential benefit: If successful, this work could lead to more accurate and timely follow-up care for patients after cervical cancer screening, potentially preventing cancer or detecting it earlier.
How similar studies have performed: While the specific integration of these complex, personalized guidelines into practice is a current challenge, the underlying screening and management principles are based on established evidence.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Haas, Jennifer S — Massachusetts General Hospital
- Study coordinator: Haas, Jennifer S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.